[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
D000284:Administration, Oral; D000368:Aged; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Potenciación de l-dopa en el Parkinson mediante un inhibidor de la decarboxilación periférica.